✦ LIBER ✦

Novel molecular targeted therapy for esophageal cancer

✍ Scribed by David S. Schrump; Dao M. Nguyen

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 66 KB
Volume: 92
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.20367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular tools for targeted imaging and

Molecular tools for targeted imaging and therapy of cancer

✍ Claude F. Meares; A. J. Chmura; Molly S. Orton; Todd M. Corneillie; Paul A Whets 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Abstract Here we review an approach to the design and production of antibody/ligand pairs for use in cell targeting procedures, to achieve functional affinity far greater than avidin/biotin. Using fundamental chemical principles, we have developed antibody/ligand pairs that retain the binding sp

Targeting mitochondria for cancer therap

Targeting mitochondria for cancer therapy

✍ David M. Hockenbery 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 1 views

Basic evidence of molecular targeted the

Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer

✍ Hiroyuki Hamakawa; Koh-ichi Nakashiro; Tomoki Sumida; Satoru Shintani; Jeffrey N 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 2 views

Novel targeted therapies in inflammatory

Novel targeted therapies in inflammatory breast cancer

✍ Massimo Cristofanilli 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

## Abstract Inflammatory breast cancer (IBC) accounts for 1% to 5% of all breast cancer cases. Its aggressive biology is characterized by rapid disease progression and poor prognosis. To improve and standardize therapy for IBC, development of novel therapeutics to molecular targets of IBC is key. T

Nutritional management during neoadjuvan

Nutritional management during neoadjuvant therapy for esophageal cancer

✍ Matthew R. Bower; Robert C.G. Martin II 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Targeted cancer therapy with novel high

Targeted cancer therapy with novel high drug-loading nanocrystals

✍ Liu, Feng (author);Park, Ji Young (author);Zhang, Yong (author);Conwell, Christi 📂 Article 📅 2010 🏛 John Wiley and Sons Inc. 🌐 English ⚖ 235 KB

A novel nanocrystal formulation of hydrophobic drugs has been developed for cancer therapy. The new method, called a three-phase nanoparticle engineering technology (3PNET), includes three phases: phase 1, amorphous precipitate; phase 2, hydrated amorphous aggregate; and phase 3, stabilized nanocrys